{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:26:57Z","timestamp":1794590817632,"version":"4.9.1"},"reference-count":29,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Few treatment options remain for patients with large B-cell lymphoma progressing after multiple lines of therapy, including the new CD19-directed antibody-drug conjugate loncastuximab tesirine (lonca). To further elucidate its efficacy and safety, we conducted a real-world analysis including data from 31 German centers. Ninety-three heavily pretreated patients received lonca in the third and later lines of therapy. Seventy-six percent had received treatment with chimeric antigen receptor T cells (n = 55), bispecific antibodies (n = 56), or both (n = 40). The overall response rate was 27%, and complete response rate was 10%. Median progression-free survival (mPFS) and median overall survival (mOS) were 2.2 and 4.4 months, respectively. The mPFS of responders was 11.4 months. Toxicity was acceptable, with grade \u22653 infections (in 13% of patients) being the most common adverse event. Patients receiving subsequent allogeneic stem cell transplantation survived significantly longer than the remaining nonconsolidated patients (mOS: 15.2 vs 3.8 months; P = .048). In multivariable analysis, no response to the last therapy before lonca (OS: hazard ratio [HR], 2.5; P = .014) and secondary International Prognostic Index (PFS\/OS: HR, \u22652.0; P \u2264 .024) were significantly associated with poor outcomes. Lonca demonstrated a favorable safety profile with moderate efficacy in heavily pretreated patients. Along with enabling timely access to subsequent therapy, efficacy in earlier lines with combination partners may further increase response rates and durability of response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026020742","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:53:41Z","timestamp":1789768421000},"page":"7751-7766","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-1729","authenticated-orcid":false,"given":"Evgenii","family":"Shumilov","sequence":"first","affiliation":[{"name":"1Department of Medicine A - Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4850-7359","authenticated-orcid":false,"given":"Lina","family":"Kolloch","sequence":"additional","affiliation":[{"name":"1Department of Medicine A - Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0025-0057","authenticated-orcid":false,"given":"Philipp","family":"Faustmann","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine II - Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora-Mich\u00e8le","family":"Grote Urtubey","sequence":"additional","affiliation":[{"name":"1Department of Medicine A - Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9800-1902","authenticated-orcid":false,"given":"Marcel","family":"Teichert","sequence":"additional","affiliation":[{"name":"3Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1632-0167","authenticated-orcid":false,"given":"Joseph","family":"Kauer","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1426-4594","authenticated-orcid":false,"given":"Meng","family":"Wang","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Oncology, and Tumor Immunology, Campus Benjamin Franklin, Charit\u00e9-University Medical Center Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Seib","sequence":"additional","affiliation":[{"name":"1Department of Medicine A - Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8858-981X","authenticated-orcid":false,"given":"Friedrich-Linus","family":"R\u00f6\u00dfiger","sequence":"additional","affiliation":[{"name":"6Department of Internal Medicine 5 - Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wurm-Kuczera","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Oncology, and Tumor Immunology, Campus Benjamin Franklin, Charit\u00e9-University Medical Center Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9279-0491","authenticated-orcid":false,"given":"Tobias","family":"Tix","sequence":"additional","affiliation":[{"name":"7Department of Medicine III, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Peeck","sequence":"additional","affiliation":[{"name":"8Department of Hematology and Oncology, Agaplesion Diakonieklinikum Rotenburg, Rotenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"H\u00e4nel","sequence":"additional","affiliation":[{"name":"9Clinic for Internal Medicine III - Hematology, Oncology and Cell Therapy, Klinikum Chemnitz, Chemnitz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8994-1137","authenticated-orcid":false,"given":"Alexander","family":"H\u00f6lscher","sequence":"additional","affiliation":[{"name":"10Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"de Bra","sequence":"additional","affiliation":[{"name":"11Department of Medicine I - Hematology, Oncology and Stem Cell Transplantation, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7887-8313","authenticated-orcid":false,"given":"Philipp","family":"G\u00f6del","sequence":"additional","affiliation":[{"name":"12Department of Internal Medicine I - Oncology, Hematology and Infectiology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Saxonis","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Oncology, and Tumor Immunology, Campus Benjamin Franklin, Charit\u00e9-University Medical Center Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belana","family":"Kuhn","sequence":"additional","affiliation":[{"name":"3Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanja","family":"Zeremski","sequence":"additional","affiliation":[{"name":"13Department of Hematology and Oncology, Medical School, Otto von Guericke University Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Ghandili","sequence":"additional","affiliation":[{"name":"14Clinic of Oncology, Hematology and Bone Marrow Transplantation with Department Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Brunner","sequence":"additional","affiliation":[{"name":"15Department of Internal Medicine IV, Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enver","family":"Aydilek","sequence":"additional","affiliation":[{"name":"16Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany"},{"name":"17Evangelisches Klinikum Bethel, University Hospital Bielefeld, Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7585-8956","authenticated-orcid":false,"given":"Markus","family":"Maulhardt","sequence":"additional","affiliation":[{"name":"16Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Mayer","sequence":"additional","affiliation":[{"name":"18Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5994-9731","authenticated-orcid":false,"given":"Philipp","family":"Nakov","sequence":"additional","affiliation":[{"name":"19Department of Internal Medicine II - Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6733-1830","authenticated-orcid":false,"given":"Christoph","family":"Brey","sequence":"additional","affiliation":[{"name":"20Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2156-6079","authenticated-orcid":false,"given":"Friedrich","family":"Gregor","sequence":"additional","affiliation":[{"name":"21Department for Hematology, Cell Therapy, Hemostaseology and Infectiology, University Hospital Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3307-2639","authenticated-orcid":false,"given":"Christian","family":"Schultze-Florey","sequence":"additional","affiliation":[{"name":"22Department of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Filippini Velazquez","sequence":"additional","affiliation":[{"name":"23Department of Hematology and Oncology, University Hospital Augsburg, Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6317-0216","authenticated-orcid":false,"given":"Paolo","family":"Mazzeo","sequence":"additional","affiliation":[{"name":"16Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany"},{"name":"24Department of Hematology and Medical Oncology, INDIGHO laboratory, University Medical Center Goettingen, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Kos","sequence":"additional","affiliation":[{"name":"25Department of Internal Medicine 1 - Oncology, Hematology, Clinical Immunology, and Rheumatology, Saarland University Medical School, Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ossami Saidy","sequence":"additional","affiliation":[{"name":"26Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kimmich","sequence":"additional","affiliation":[{"name":"27Department of Oncology and Hematology, University Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maika","family":"Klaiber-Hakimi","sequence":"additional","affiliation":[{"name":"28Department of Oncology, Hematology and Palliative Medicine, Marien Hospital Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4152-0366","authenticated-orcid":false,"given":"Philipp","family":"Berning","sequence":"additional","affiliation":[{"name":"1Department of Medicine A - Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6904-2821","authenticated-orcid":false,"given":"Andrea","family":"Kerkhoff","sequence":"additional","affiliation":[{"name":"1Department of Medicine A - Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Glass","sequence":"additional","affiliation":[{"name":"26Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Kr\u00e4mer","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8167-2989","authenticated-orcid":false,"given":"Lorenz","family":"Thurner","sequence":"additional","affiliation":[{"name":"25Department of Internal Medicine 1 - Oncology, Hematology, Clinical Immunology, and Rheumatology, Saarland University Medical School, Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2572-5687","authenticated-orcid":false,"given":"Mathias","family":"Lutz","sequence":"additional","affiliation":[{"name":"23Department of Hematology and Oncology, University Hospital Augsburg, Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-1955","authenticated-orcid":false,"given":"Florian","family":"Heidel","sequence":"additional","affiliation":[{"name":"22Department of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8398-285X","authenticated-orcid":false,"given":"Vladan","family":"Vu\u010dini\u0107","sequence":"additional","affiliation":[{"name":"21Department for Hematology, Cell Therapy, Hemostaseology and Infectiology, University Hospital Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Pott","sequence":"additional","affiliation":[{"name":"19Department of Internal Medicine II - Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7682-8563","authenticated-orcid":false,"given":"Kai","family":"Wille","sequence":"additional","affiliation":[{"name":"29University Clinic for Hematology, Oncology, Hemostaseology and Palliative Medicine, Johannes Wesling Hospital Minden, Ruhr University Bochum, Minden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5094-6887","authenticated-orcid":false,"given":"Ulrike","family":"Kolar-Michaelis","sequence":"additional","affiliation":[{"name":"30Department of Hematology and Oncology, RoMed Klinikum Rosenheim, Rosenheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0322-3209","authenticated-orcid":false,"given":"Karin","family":"Schmitz","sequence":"additional","affiliation":[{"name":"19Department of Internal Medicine II - Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany"},{"name":"31Department of Hematology and Oncology, DIAKO Krankenhaus Bremen, Bremen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Viardot","sequence":"additional","affiliation":[{"name":"20Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald G.","family":"Wulf","sequence":"additional","affiliation":[{"name":"16Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-9348","authenticated-orcid":false,"given":"Thomas","family":"Weber","sequence":"additional","affiliation":[{"name":"15Department of Internal Medicine IV, Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-6660","authenticated-orcid":false,"given":"Dimitrios","family":"Mougiakakos","sequence":"additional","affiliation":[{"name":"13Department of Hematology and Oncology, Medical School, Otto von Guericke University Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Ayuk","sequence":"additional","affiliation":[{"name":"32Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Holtick","sequence":"additional","affiliation":[{"name":"12Department of Internal Medicine I - Oncology, Hematology and Infectiology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-1832","authenticated-orcid":false,"given":"Sascha","family":"Dietrich","sequence":"additional","affiliation":[{"name":"10Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-0128","authenticated-orcid":false,"given":"Leo","family":"Hansmann","sequence":"additional","affiliation":[{"name":"18Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0566-4554","authenticated-orcid":false,"given":"Niklas","family":"Gebauer","sequence":"additional","affiliation":[{"name":"33Department for Hematology and Oncology, Campus Luebeck, University Hospital Schleswig-Holstein, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Schnetzke","sequence":"additional","affiliation":[{"name":"34Department of Internal Medicine II, University Hospital Jena, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Marks","sequence":"additional","affiliation":[{"name":"11Department of Medicine I - Hematology, Oncology and Stem Cell Transplantation, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0358-5249","authenticated-orcid":false,"given":"Martin","family":"Dreyling","sequence":"additional","affiliation":[{"name":"7Department of Medicine III, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dreger","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6485-8773","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Chapuy","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Oncology, and Tumor Immunology, Campus Benjamin Franklin, Charit\u00e9-University Medical Center Berlin, Berlin, Germany"},{"name":"35German Cancer Consortium, partner site Berlin, a partnership between German Cancer Consortium and Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-5839","authenticated-orcid":false,"given":"Fabian","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"6Department of Internal Medicine 5 - Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1410-4487","authenticated-orcid":false,"given":"Bastian","family":"von Tresckow","sequence":"additional","affiliation":[{"name":"3Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2494-9862","authenticated-orcid":false,"given":"Stefan","family":"Wirths","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine II - Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Schmitz","sequence":"additional","affiliation":[{"name":"1Department of Medicine A - Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lenz","sequence":"additional","affiliation":[{"name":"1Department of Medicine A - Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2026111311222130000_bib1","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"2026111311222130000_bib2","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/s41375-023-01962-5","article-title":"Correction: \u201cThe 5th edition of The World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms\u201d Leukemia. 2022 Jul;36(7):1720-1748","volume":"37","author":"Alaggio","year":"2023","journal-title":"Leukemia"},{"key":"2026111311222130000_bib3","doi-asserted-by":"crossref","first-page":"20406207221103321","DOI":"10.1177\/20406207221103321","article-title":"Current options and future perspectives in the treatment of patients with relapsed\/refractory diffuse large B-cell lymphoma","volume":"13","author":"Frontzek","year":"2022","journal-title":"Ther Adv Hematol"},{"issue":"16","key":"2026111311222130000_bib4","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","article-title":"Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study","volume":"130","author":"Crump","year":"2017","journal-title":"Blood"},{"issue":"26","key":"2026111311222130000_bib5","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"2026111311222130000_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N Engl J Med"},{"issue":"10254","key":"2026111311222130000_bib7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(20)31366-0","article-title":"Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study","volume":"396","author":"Abramson","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"2026111311222130000_bib8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N Engl J Med"},{"issue":"14","key":"2026111311222130000_bib9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood.2022018730","article-title":"Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study","volume":"141","author":"Abramson","year":"2023","journal-title":"Blood"},{"issue":"10466","key":"2026111311222130000_bib10","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(24)01774-4","article-title":"Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial","volume":"404","author":"Abramson","year":"2024","journal-title":"Lancet"},{"issue":"24","key":"2026111311222130000_bib11","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa2206913","article-title":"Glofitamab for relapsed or refractory diffuse large B-cell lymphoma","volume":"387","author":"Dickinson","year":"2022","journal-title":"N Engl J Med"},{"issue":"12","key":"2026111311222130000_bib12","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1038\/s41375-024-02410-8","article-title":"Epcoritamab in relapsed\/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial","volume":"38","author":"Thieblemont","year":"2024","journal-title":"Leukemia"},{"issue":"suppl 1","key":"2026111311222130000_bib13","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1182\/blood-2025-5519","article-title":"Sustained clinical benefit of glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab plus GemOx (R-GemOx) in patients with relapsed\/refractory (R\/R) diffuse large B-cell lymphoma (DLBCL): 3-year follow-up of STARGLO","volume":"146","author":"Abramson","year":"2025","journal-title":"Blood"},{"issue":"6","key":"2026111311222130000_bib14","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/bjh.19860","article-title":"Sequencing of therapy for patients with diffuse large B-cell lymphoma in the era of novel drugs","volume":"205","author":"Karsten","year":"2024","journal-title":"Br J Haematol"},{"issue":"10","key":"2026111311222130000_bib15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood-2017-10-813493","article-title":"ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignancies","volume":"131","author":"Zammarchi","year":"2018","journal-title":"Blood"},{"issue":"6","key":"2026111311222130000_bib16","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(21)00139-X","article-title":"Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial","volume":"22","author":"Caimi","year":"2021","journal-title":"Lancet Oncol"},{"issue":"14","key":"2026111311222130000_bib17","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1158\/1078-0432.CCR-23-1962","article-title":"Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma","volume":"30","author":"Lownik","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2026111311222130000_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jha2.816","article-title":"In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine","volume":"5","author":"Caimi","year":"2024","journal-title":"EJHaem"},{"issue":"3","key":"2026111311222130000_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3324\/haematol.2024.285977","article-title":"Loncastuximab in high-risk and heavily pretreated relapsed\/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers","volume":"110","author":"Zelikson","year":"2025","journal-title":"Haematologica"},{"issue":"3","key":"2026111311222130000_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/14796694.2024.2418751","article-title":"Understanding how CD19 expression levels impact the response to loncastuximab tesirine: a plain language summary","volume":"21","author":"Caimi","year":"2025","journal-title":"Future Oncol"},{"issue":"1","key":"2026111311222130000_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41408-024-01195-4","article-title":"Outcomes with loncastuximab tesirine following CAR T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma","volume":"14","author":"Epperla","year":"2024","journal-title":"Blood Cancer J"},{"issue":"9","key":"2026111311222130000_bib22","doi-asserted-by":"crossref","first-page":"e70207","DOI":"10.1002\/hem3.70207","article-title":"Large B-cell lymphoma (LBCL): EHA clinical practice guidelines for diagnosis, treatment, and follow-up","volume":"9","author":"Thieblemont","year":"2025","journal-title":"Hemasphere"},{"issue":"27","key":"2026111311222130000_bib23","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"2026111311222130000_bib24","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf."},{"issue":"4","key":"2026111311222130000_bib25","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3324\/haematol.2023.283459","article-title":"Loncastuximab tesirine in relapsed\/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study","volume":"109","author":"Caimi","year":"2024","journal-title":"Haematologica"},{"issue":"1","key":"2026111311222130000_bib26","doi-asserted-by":"crossref","first-page":"S756","DOI":"10.1016\/S2152-2650(25)02296-7","article-title":"ABCL-758: updated safety run-in results from LOTIS-5: a phase 3, randomized trial of loncastuximab tesirine with rituximab versus immunochemotherapy in patients with R\/R DLBCL\/HGBL","volume":"25","author":"Carlo-Stella","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2026111311222130000_bib27","author":"Carlo-Stella","year":"12  2025"},{"key":"2026111311222130000_bib28","author":"Alderuccio","year":"17-22  2025"},{"key":"2026111311222130000_bib29","author":"Alderuccio","year":"12-15  2025"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/22\/7751\/2600565\/blooda_adv-2026-020742-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/22\/7751\/2600565\/blooda_adv-2026-020742-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:22:35Z","timestamp":1794586955000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/22\/7751\/571044\/Loncastuximab-tesirine-in-heavily-pretreated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,24]]},"references-count":29,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026,11,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026020742","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,24]]},"published":{"date-parts":[[2026,11,24]]}}}